Live Updates: COVID-19 Cases
  • World 30,384,219
    World
    Confirmed: 30,384,219
    Active: 7,368,160
    Recovered: 22,064,876
    Death: 951,183
  • USA 6,876,126
    USA
    Confirmed: 6,876,126
    Active: 2,517,956
    Recovered: 4,155,933
    Death: 202,237
  • India 5,214,677
    India
    Confirmed: 5,214,677
    Active: 1,017,722
    Recovered: 4,112,551
    Death: 84,404
  • Brazil 4,457,443
    Brazil
    Confirmed: 4,457,443
    Active: 569,330
    Recovered: 3,753,082
    Death: 135,031
  • Russia 1,091,186
    Russia
    Confirmed: 1,091,186
    Active: 170,784
    Recovered: 901,207
    Death: 19,195
  • Peru 750,098
    Peru
    Confirmed: 750,098
    Active: 124,439
    Recovered: 594,513
    Death: 31,146
  • Mexico 684,113
    Mexico
    Confirmed: 684,113
    Active: 123,518
    Recovered: 488,416
    Death: 72,179
  • South Africa 655,572
    South Africa
    Confirmed: 655,572
    Active: 54,497
    Recovered: 585,303
    Death: 15,772
  • Spain 625,651
    Spain
    Confirmed: 625,651
    Active: 595,246
    Recovered: ?
    Death: 30,405
  • Chile 441,150
    Chile
    Confirmed: 441,150
    Active: 15,080
    Recovered: 413,928
    Death: 12,142
  • Iran 416,198
    Iran
    Confirmed: 416,198
    Active: 36,741
    Recovered: 355,505
    Death: 23,952
  • France 415,481
    France
    Confirmed: 415,481
    Active: 293,546
    Recovered: 90,840
    Death: 31,095
  • UK 381,614
    UK
    Confirmed: 381,614
    Active: 339,909
    Recovered: ?
    Death: 41,705
  • Bangladesh 345,805
    Bangladesh
    Confirmed: 345,805
    Active: 88,589
    Recovered: 252,335
    Death: 4,881
  • Saudi Arabia 328,144
    Saudi Arabia
    Confirmed: 328,144
    Active: 16,538
    Recovered: 307,207
    Death: 4,399
  • Pakistan 304,386
    Pakistan
    Confirmed: 304,386
    Active: 6,295
    Recovered: 291,683
    Death: 6,408
  • Turkey 298,039
    Turkey
    Confirmed: 298,039
    Active: 26,979
    Recovered: 263,745
    Death: 7,315
  • Italy 293,025
    Italy
    Confirmed: 293,025
    Active: 41,413
    Recovered: 215,954
    Death: 35,658
  • Germany 269,298
    Germany
    Confirmed: 269,298
    Active: 18,539
    Recovered: 241,300
    Death: 9,459
  • Canada 140,867
    Canada
    Confirmed: 140,867
    Active: 8,558
    Recovered: 123,109
    Death: 9,200
  • Netherlands 88,073
    Netherlands
    Confirmed: 88,073
    Active: 81,807
    Recovered: ?
    Death: 6,266
  • China 85,255
    China
    Confirmed: 85,255
    Active: 165
    Recovered: 80,456
    Death: 4,634
  • Australia 26,861
    Australia
    Confirmed: 26,861
    Active: 2,169
    Recovered: 23,855
    Death: 837
  • S. Korea 22,783
    S. Korea
    Confirmed: 22,783
    Active: 2,635
    Recovered: 19,771
    Death: 377
  • New Zealand 1,809
    New Zealand
    Confirmed: 1,809
    Active: 70
    Recovered: 1,714
    Death: 25

Some immunosuppressants do not increase COVID-19 risk: Scientists

Author at TechGenyz Health
Covid-19 On Health
Credit: envatoelements

Therapeutics which suppress the immune system in those with inflammatory diseases like psoriasis and rheumatoid arthritis “is not associated with a significantly greater risk” for contracting COVID-19, according to a study which says these patients should continue taking their medicine as prescribed.

Dermatology researchers from the Henry Ford Health System in the US, which treats a large number of patients with inflammatory diseases like psoriasis, eczema and lupus, said most of these patients are not at any greater risk for COVID-19 than the general population, despite their weakened immune system.

While patients who are immunosuppressed are predisposed to upper respiratory infections like the common cold, which may cause coughing, a runny nose and a sore throat, the scientists said this patient population has not been reported to be at higher risk for COVID-19 to date.

According to the researchers, the study, published in the Journal of the American Academy of Dermatology, is one of the first to analyse the association between immunosuppressive medications for skin diseases and the risk of COVID-19 infection and outcomes.

“If you require an immune suppressant medication for your condition to be well controlled, you should not be afraid to continue that medication during the pandemic,” said Jesse Veenstra, a Henry Ford dermatologist and the study’s lead author.

The researchers noted that until now, very little was known about managing patients on these medications in the pandemic, and whether they may be at increased risk for infection with COVID-19, or related complications because of their weakened immune system.

In the current study, they conducted a retrospective analysis of 213 patients who were taking immunosuppressive medication for immune-mediated inflammatory disease.

They tested the patients who had been receiving immunosuppressive medication for at least one month prior to being tested for COVID-19 between February 1 and April 18.

The study found that 36 per cent of the 213 patients tested COVID-19 positive, and had no greater odds of being hospitalised or placed on a ventilator than the general population.

The scientists said they did not find any evidence of an immunosuppressive medication increasing a patient’s odds for testing positive or developing serious disease.

Patients prescribed a TNF alpha inhibitor, which is protein therapeutics part of a class of immunosuppressive agents, had significantly lower odds for hospitalisation, the study noted.

On the contrary, Veenstra said, patients who were on multidrug therapy regimens were at greater odds of being hospitalised than those taking a single medication.

He added that more research is needed to fully explain this finding.

Citing the limitations of the research, the scientists noted that being a single-center study, the findings may not be easily generalised to other communities.

They added that only patients who tested for COVID-19 were analysed in the study.

However, the researchers believe the findings suggest that multiple medications further suppress a patient’s immune system, thus rendering them more susceptible to COVID-19.

“Traditionally, you think of these medications putting you at higher risk for infection,” Veenstra said.

“With COVID-19, this is a new type of pathogen, and no one really knows how these medications affect your immune system’s ability to deal with the infection,” he added.

Career

Subscribe